UBS Group AG is navigating a critical juncture where its capital strategy and shareholder returns are directly tied to an impending political decision in Bern. The Swiss parliament is set to deliberate on new banking regulations that could force the bank to allocate billions in capital, potentially at the expense of a planned $3 billion share buyback program. The outcome will shape the financial giant’s flexibility for years to come.
At the heart of the debate are two regulatory packages from the Swiss Federal Council. The most significant change concerns how UBS must fund its foreign subsidiaries. Current rules require backing of just over half, but the proposed amendment would mandate a full 100% deduction from the parent company’s core equity tier 1 (CET1) capital. If enacted, this could require UBS to inject approximately $3 billion in fresh capital into its Swiss unit. This sum is identical to the volume earmarked for its share repurchase program slated for 2026, presenting the bank with a stark either-or scenario.
The government’s final proposal, sent to parliament on April 22, outlines that the combined regulatory packages would create an additional capital requirement of around $20 billion for the Swiss entity. Adjustments to capital adequacy rules alone are expected to reduce the UBS Group’s CET1 ratio by about 0.8 percentage points, a net reduction of $4 billion. Bank management has pushed back strongly, labeling parts of the government’s documentation as misleading and is conducting a detailed review. UBS maintains that since the rules are not expected to take effect before 2027, its current strategic targets remain unchanged.
Operationally, the bank continues to show robust performance, providing a solid backdrop to the regulatory tussle. The integration of Credit Suisse is progressing ahead of schedule. Gross cost savings have already reached $10.7 billion, exceeding internal targets. The bank achieved its cost-saving goal a quarter early, with $10 billion saved to date, representing 77% of the total $13 billion target set for the end of 2026. The technical integration is also advanced, with about 85% of former Credit Suisse client accounts in Switzerland already running on the new IT platform.
Should investors sell immediately? Or is it worth buying UBS?
Shareholders have recently signaled strong support for the bank’s capital management. At the Annual General Meeting on April 15, investors voted 94% in favor of canceling shares repurchased under the 2024 buyback program. The meeting also saw the election of three new board members: Agustín Carstens, Luca Maestri, and Markus Ronner.
The stock market has responded positively to the operational progress. Over the past 30 days, UBS shares have climbed roughly 13% to trade at 36.46 euros. While the stock remains down since the start of the year, it has recovered more than 38% from its low last summer, with its 50-day moving average suggesting a technical recovery is underway.
Attention now turns to a series of key dates. The bank will report its first-quarter 2026 results on April 29, where it is expected to disclose recent wealth management inflows and likely comment on the regulatory plans. Market consensus anticipates revenue of up to $11.7 billion for the quarter. For the full year 2025, UBS posted a net profit of $7.8 billion, a 53% increase from the prior year.
Politically, the next step occurs on May 4, when the Economic Affairs Committee of the Council of States will debate the banking law. Parliament holds the final decision, and some legislators have previously warned against overregulation that could weaken the Swiss financial center. UBS’s leadership reaffirmed its return on CET1 capital target of approximately 15% through the end of 2026, alongside a targeted cost-to-income ratio below 70%. Planned capital returns to shareholders for the current year also remain in place, for now. The coming parliamentary process will determine whether both the bank’s stability mandates and its promises to investors can be simultaneously fulfilled.
Ad
UBS Stock: Buy or Sell?! New UBS Analysis from April 23 delivers the answer:
The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 23.
UBS: Buy or sell? Read more here...
